Holding(s) in Company

RNS Number : 6126D

Allergy Therapeutics PLC

17 May 2012

 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii		Allergy Therapeutics Plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify): Update to Total Voting Rights figure triggered this notification				X
3. Full name of person(s) subject to the notification obligation: iii	M&G Investment Funds 3
4. Full name of shareholder(s)  (if different from 3.):iv	State Street Noms Ltd A/C GMIR
5. Date of the transaction and date on which the threshold is crossed or reached: v	16 May 2012
6. Date on which issuer notified:	17 May 2012
7. Threshold(s) that is/are crossed or reached: vi, vii	See Item 13

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORD GBP0.001 GB00B02LCQ05

16,732,764

16,732,764

Below 5%

Below 5%

Below 5%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

Below 5%

Below 5%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:		N/A
11. Number of voting rights proxy holder will cease to hold:		N/A
12. Date on which proxy holder will cease to hold voting rights:		N/A
13. Additional information:	With reference to item 3, M&G Investments Funds 3 is an Open Ended Investment Company (OEIC) and is not a Prudential group company and must be separately disclosed. This OEIC Fund is managed by M&G Investment Management Limited (a wholly owned subsidiary of Prudential plc) and will have been previously attributed to Prudential plc solely on the basis that M&G Investment Management Ltd has direct fund management control over the shares identified in this notification.  Therefore the Below 5% holding being disclosed in this notification is encompassed in the Below 5% already disclosed under The Prudential plc group of companies and is NOT in addition to it.
14. Contact name:	James Todd / Mark Thomas M&G Investment Management Limited
15. Contact telephone number:	020 7548 2293 / 020 7548 3266

 

END

 

 

HOLUBVVRUAAVAAR